RxDoctor Payments Data

Matthew Hanasono, MD

Plastic and Reconstructive Surgery · Houston, TXNPI 1790883999

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $12,870 of the $19,025 with a category attached, or 67.6%. Medical Device Business Services, Inc. accounts for 71.8% of it on its own, with 9 other manufacturers making up the rest. Among plastic and reconstructive surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,025in general payments, 2019–2025

Across 24 payments — averaging $792.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$14K
  • Synthes GmbH$4K
  • Baxter Healthcare$407
  • AbbVie$280
  • Medtronic$165
  • Axogen$156
  • plus $402 from 4 others

What the payments were for

  • Consulting fees$12,87068%
  • Speaking & faculty fees$1,5008%
  • Travel & lodging$3,09616%
  • Food & beverage$1,5598%

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,025 in reported general payments places this provider in the 90th percentile of 378 plastic and reconstructive surgery providers in Texas.

See all plastic and reconstructive surgery providers in Texas

Medicare billing

Part B allowed, 2024
$103,469
Medicare patients
56
Services billed
196

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other plastic and reconstructive surgery in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →